Research by Area of Interest
Can Exosomes Help With Hair Loss? What the Research Says
Explore what laboratory and human studies have investigated about extracellular vesicles, hair follicles, androgenetic alopecia, hair density and hair growth.
What Does the Research Show?
The early human evidence is promising, but it is not yet definitive. A 2025 systematic review identified 11 human studies, including two randomized controlled trials, evaluating exosome-based approaches for hair loss. Every included study reported improvement in at least one measured hair outcome, but the researchers also emphasized major differences in EV source, preparation, delivery method and study design. Larger standardized trials are still needed. That means there is a legitimate scientific reason for interest in EVs and hair regeneration — but results from one study should not automatically be generalized to every exosome product.
About the Research Discussed Here
The studies on this page did not evaluate HydroKarma. They used different extracellular-vesicle preparations, including cultured-cell-derived and other EV products. According to KWEHEALTH-supplied information, HydroKarma is produced from refined human amniotic fluid, not cultured-cell expansion. Research involving foreskin MSC-derived, adipose-derived or other EV preparations therefore should not be interpreted as clinical evidence that HydroKarma produces the same outcomes. The value of reviewing this literature is to understand why extracellular vesicles are being investigated in hair biology — not to claim that every EV product is interchangeable.
Hair loss is one of the most common reasons people become interested in exosomes and extracellular vesicles.
The obvious question is: can exosomes actually help with hair growth?
Researchers have begun studying several different exosome and EV preparations in androgenetic alopecia and other forms of nonscarring hair loss. Early human studies have reported encouraging changes in measures such as hair density, hair thickness and patient-reported improvement, but the research is still developing.
Why Are Researchers Studying Exosomes for Hair Loss?
Hair follicles constantly cycle through phases of growth, transition and rest. In androgenetic alopecia, follicles gradually miniaturize and produce thinner, shorter hairs over time.
Extracellular vesicles are being studied because they carry proteins, lipids, RNA and other signaling molecules between cells. Laboratory research suggests certain EV preparations can influence pathways involved in dermal papilla cells, hair-follicle activity and the hair-growth cycle. For background on the particles themselves, see where exosomes come from.
That biological interest has now moved beyond laboratory studies into early human research. The three human studies most often cited are summarized below.
What Do Reviews of the Human Evidence Say?
The growing number of individual studies has led researchers to review the clinical literature as a whole.
A 2025 systematic review identified 11 human studies, including two randomized trials, three retrospective studies, three prospective single-arm studies, a case series and two case reports. The studies collectively reported improvements in measures including hair density, thickness and patient satisfaction, but varied considerably in methodology and EV preparation.
Another review focusing on human alopecia research identified nine relevant clinical studies involving 125 patients who received exosome-based interventions. It described the early evidence as promising while emphasizing the need for standardized products, protocols and safety reporting.
So the overall picture isn't: “One study proved exosomes regrow hair.” It's more accurately: multiple early human studies have reported encouraging hair-growth-related findings, and researchers now have enough clinical evidence to justify larger, better-controlled trials.
Can Exosomes Regrow Hair?
Some studies have reported increases in hair density, thickness and visible regrowth measures. That is encouraging. But the word “regrow” can imply a certainty that the evidence doesn't support yet.
Research has used different:
- EV sources
- manufacturing methods
- concentrations
- delivery approaches
- treatment schedules
- outcome measurements
And androgenetic alopecia is not the same as every other cause of hair loss. So it's more accurate to say that exosome/EV-based approaches are being actively investigated for their potential to promote hair growth and improve measurable hair parameters. Differences between preparations are covered in are all exosome products the same?.
What About Exosomes vs. PRP for Hair Loss?
Both PRP and EV-based approaches are being investigated in hair restoration. PRP is prepared from the patient's own blood, while manufactured EV products may come from external biological sources and can be characterized batch by batch.
Some recent reviews have compared exosomes, PRP and conventional approaches, but direct high-quality head-to-head clinical evidence remains limited. For the broader comparison, see Exosomes vs. PRP: What's the Difference?.
Why Results May Vary
As with many biologically active interventions, people may not respond identically. Individual genetics, age, underlying biology, disease severity and other person-specific factors may influence biological responses. The extracellular-vesicle preparation itself—including its source, manufacturing, characterization and formulation—may also matter. Researchers are still working to understand which factors may help predict how individuals respond.
The Bottom Line
Research into extracellular vesicles and hair loss has moved beyond laboratory experiments. Several human studies have now reported encouraging changes in hair density, hair thickness, visible regrowth measures and patient satisfaction, and systematic reviews describe the field as promising.
At the same time, the clinical literature is still relatively small and uses widely different EV sources and protocols.
Individual results can vary
Promising results in a study do not mean every person will experience the same result. Individual responses can vary, and researchers are still investigating why.
Promising is not the same as proven
The evidence supports saying: exosomes and extracellular vesicles are a promising and actively studied area of hair-regeneration research. It does not yet support saying: every exosome product has been proven to regrow hair. If you are comparing products, see how to evaluate an exosome product before you buy.
Research Highlights
Effectiveness of Exosome Treatment in Androgenetic Alopecia: Outcomes of a Prospective Study
Aesthetic Plastic Surgery · 2024 · People with androgenetic alopecia (authors assigned Level of Evidence IV)
Foreskin-derived mesenchymal stromal cell–derived exosomes
- What researchers studied
- Researchers evaluated foreskin-derived mesenchymal stromal cell exosomes in people with androgenetic alopecia.
- What researchers found
- The study reported a statistically significant increase in hair density at both four and twelve weeks after administration, along with increased patient satisfaction at twelve weeks.
- Why this is interesting
- The study measured actual hair density rather than relying only on subjective photographs.
- Important limitation
- This was a prospective Level IV study rather than a large randomized controlled trial, and it evaluated a specific cultured-cell-derived preparation — not HydroKarma.
DOI: 10.1007/s00266-024-04332-3 · PMID: 39174804
The efficacy of adipose stem cell-derived exosomes in hair regeneration based on a preclinical and clinical study
International Journal of Dermatology · 2024 · Preclinical work plus a clinical component in androgenetic alopecia
Adipose stem cell–derived exosome preparation
- What researchers studied
- This study investigated an adipose stem cell-derived exosome preparation using both preclinical and clinical components.
- What researchers found
- The authors reported favorable findings involving hair regeneration and concluded that the clinical portion contributed to growing evidence for exosome-based approaches in androgenetic alopecia.
- Why this is interesting
- It connects biological/preclinical observations with human clinical evaluation.
- Important limitation
- The preparation was adipose-stem-cell-derived, and the study had industry involvement that should be considered when interpreting the findings.
DOI: 10.1111/ijd.17406 · PMID: 39155501
A Prospective Study of Exosome Therapy for Androgenetic Alopecia
Aesthetic Plastic Surgery · 2025 · Patients with androgenetic alopecia; exosome application combined with microneedling (Level of Evidence IV)
Exosome-based preparation applied together with microneedling
- What researchers studied
- A prospective study evaluated an exosome-based approach combined with microneedling in patients with androgenetic alopecia.
- What researchers found
- At 12 months, the researchers reported an average increase in hair density of 35 hairs/cm². They also reported that 80% of participants noticed improvement in hair regrowth and 87% reported being satisfied or highly satisfied.
- Why this is interesting
- The study included a 12-month follow-up and reported both objective hair-density measurements and patient-reported outcomes.
- Important limitation
- This was a Level IV prospective study without a placebo control, and because microneedling was used together with the exosome preparation, the study cannot isolate the contribution of the EV product alone.
DOI: 10.1007/s00266-025-04817-9 · PMID: 40146273
Original Sources / References
- Ersan M, Ozer E, Akin O et al. — Effectiveness of Exosome Treatment in Androgenetic Alopecia: Outcomes of a Prospective Study. Aesthetic Plastic Surgery, 2024. DOI: 10.1007/s00266-024-04332-3 (PMID 39174804). Prospective, uncontrolled study; authors assigned Level of Evidence IV.
- Lee E, Choi MS, Cho BS et al. — The efficacy of adipose stem cell-derived exosomes in hair regeneration based on a preclinical and clinical study. International Journal of Dermatology, 2024. DOI: 10.1111/ijd.17406 (PMID 39155501). Preclinical plus clinical evaluation with industry involvement.
- Wan J, Kim SB, Cartier H et al. — A Prospective Study of Exosome Therapy for Androgenetic Alopecia. Aesthetic Plastic Surgery, 2025. DOI: 10.1007/s00266-025-04817-9 (PMID 40146273). Prospective, open-label study in which exosome application followed microneedling.
- Al Ameer MA, Alnajim AT, Al Ameer A et al. — Exosomes and Hair Regeneration: A Systematic Review of Clinical Evidence Across Alopecia Types and Exosome Sources. Clinical, Cosmetic and Investigational Dermatology, 2025;18:2215-2227. DOI: 10.2147/CCID.S543451 (PMID 40955427). Eleven human studies, including two randomized controlled trials.
- Queen D, Avram MR. — Exosomes for Treating Hair Loss: A Review of Clinical Studies. Dermatologic Surgery, 2025;51(4):409-415. DOI: 10.1097/DSS.0000000000004480 (PMID 39447204). Nine clinical studies relevant to alopecia covering 125 patients, with a call for standardized products, protocols and safety reporting.
Continue Learning
Exosomes vs. PRP: What's the Difference?
A balanced comparison of platelet-rich plasma and manufactured extracellular vesicle products: where each starts, how consistency differs, and what buyers should ask about.
Where Do Exosomes Come From? Comparing Common Sources
Extracellular vesicles can be obtained from biological fluids such as amniotic fluid or collected from cells grown in culture. Why the source changes the questions a buyer should ask.
Are All Exosome Products the Same?
Exosome and extracellular-vesicle products can differ in source, manufacturing approach, particle testing, characterization, documentation, format, storage and fulfillment.
How to Evaluate an Exosome Product Before You Buy
Seven practical things to check before buying an exosome product — manufacturer, biological source, batch-specific COA, particle-count method, finished-product testing, cold-chain handling and verifiable claims.
